Vikas Sinha is the Chief Financial Officer and co-founder of ElevateBio, Life Edit’s parent company. He brings more than 25 years of experience in executive finance roles in the life sciences industry and also serves as President and Chief Financial Officer of AlloVir.
Prior to ElevateBio, Vikas served as CFO of Alexion Pharmaceuticals for 11 years, where he was responsible for finance, business development, strategy, and IT. During his tenure as CFO, Alexion’s market cap grew from $600 million to more than $30 billion and revenue grew from zero to more than $3 billion.
Prior to joining Alexion, Vikas held various positions with Bayer AG in the United States, Japan, Germany, and Canada, including Vice President and CFO of Bayer Pharmaceuticals Corporation, U.S. and VP and CFO of Bayer Yakuhin Ltd., in Japan. He serves as an independent board member and Audit Committee Chair of Verona Pharma Inc.
Vikas received his MBA from the Asian Institute of Management, Manila, Philippines. He is a qualified Chartered Accountant and associate member of the Institute of Chartered Accountants of India and a Certified Public Accountant in the United States.
